Abstract |
The patient was a 70-year-old male with advanced cancers of stomach and rectum and multiple metastatic hepatic tumors. No resectability was detected. The origin of metastatic hepatic tumors was unknown, so the combination of S- / 1 and CPT-11 as a treatment regimen was selected. S-1, 80 mg m(2), was administered on 14 consecutive days followed / by a 14-day rest period, and CPT-11, 100 mg/m(2), was administered on day 1 and day 15. One cycle was defined as 4 weeks, and cycles were repeated. CR was achieved as long as metastatic hepatic tumors after completion of 5 cycles. When we encounter a case of simultaneous double cancers with metastatic sites which has no respectability, generally speaking, it is difficult to determine the strategy for chemotherapy. This case suggests that the combination of S-1 and CPT-11 may be an effective regimen for the treatment of simultaneous advanced cancers of stomach and rectum with multiple hepatic metastases.
|
Authors | Toshiro Iizuka, Naoki Hirano, Daisuke Kikuchi, Shu Hoteya, Naohisa Yahagi |
Journal | Gan to kagaku ryoho. Cancer & chemotherapy
(Gan To Kagaku Ryoho)
Vol. 36
Issue 1
Pg. 139-41
(Jan 2009)
ISSN: 0385-0684 [Print] Japan |
PMID | 19151581
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Carcinoembryonic Antigen
- Drug Combinations
- S 1 (combination)
- Tegafur
- Oxonic Acid
- Irinotecan
- Camptothecin
|
Topics |
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Biopsy
- Camptothecin
(analogs & derivatives, therapeutic use)
- Carcinoembryonic Antigen
(blood)
- Drug Combinations
- Endoscopy, Gastrointestinal
- Humans
- Irinotecan
- Liver Neoplasms
(blood, diagnostic imaging, drug therapy, secondary)
- Male
- Neoplasms, Multiple Primary
(blood, drug therapy, pathology)
- Oxonic Acid
(therapeutic use)
- Rectal Neoplasms
(blood, drug therapy, pathology, surgery)
- Stomach Neoplasms
(blood, drug therapy, pathology, surgery)
- Tegafur
(therapeutic use)
- Tomography, X-Ray Computed
- Treatment Outcome
|